Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PREDICT-HF

Financiado

Cerrado

Predicting Outcome of Rate or Rhythm Control in Patients with Atrial Fibrillatio...

Predicting Outcome of Rate or Rhythm Control in Patients with Atrial Fibrillation and Heart Failure Heart failure (HF) and atrial fibrillation (AF) are common co-morbidities (AF-HF). AF-HF is prevalent in Europe with high rates of hospitalisation and death. AF-HF patients have two treatment options: rate control, where AF is not... ver más

31/08/2026

IMPERIAL COLLEGE O...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-05-14

ERC-2019-COG: ERC Consolidator Grant

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

IMPERIAL COLLEGE OF SCIENCE...

1.05M€ | Lider

ACUICOLA MARINA

354.06K€ | Participante

KINGS COLLEGE LONDON

949.15K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MMAF Novel multimodal approach to atrial fibrillation risk assess... 2M€ Cerrado

PID2019-104356RB-C41 MODELO MULTIESCALA DE PATOLOGIAS CARDIACAS Y OPTIMIZACION DE... 198K€ Cerrado

COMHEART2CLINIC Translation of Computational Heart Models into the Clinic 30K€ Cerrado

PID2019-104356RB-C43 MODELO COMPUTACIONAL MECANO-ELECTRICO DE CORAZON HUMANO PARA... 138K€ Cerrado

PID2020-114291RB-I00 GEMELOS VIRTUALES INTELLIGENTES DEL CORAZON PARA ESTRATIFICA... 151K€ Cerrado

DPI2016-75799-R TECNOLOGIAS COMPUTACIONALES PARA LA OPTIMIZACION DE TERAPIAS... 122K€ Cerrado

Duración del proyecto: 75 meses Fecha Inicio: 2020-05-14
Fecha Fin: 2026-08-31

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Heart failure (HF) and atrial fibrillation (AF) are common co-morbidities (AF-HF). AF-HF is prevalent in Europe with high rates of hospitalisation and death. AF-HF patients have two treatment options: rate control, where AF is not treated but drugs are used to slow the heart rate, or rhythm control, where AF is treated to restore sinus rhythm. Rate control is the first-line treatment, yet specific patient groups do much better under rhythm control. Identifying patients that will do best under rhythm control remains a significant clinical challenge. Potential responders to rhythm control can be identified by their disease history, however, this is often unknown, or their response to treatment, which can only be observed once the therapy has been delivered. We propose to address these challenges by developing patient specific biophysical cardiac models to infer patient history and predict patient response to treatment to inform optimal therapy selection for individual patients. A model for simulating AF-HF in human hearts, representing all four cardiac chambers, will be created. Bayesian uncertainty quantification techniques will be used to combine physical laws, physiology, population data and measurements from individual patients into cardiac models that account for data uncertainty in model parameters and simulation predictions. Patient specific cardiac models will be used to answer three critical clinical questions in prospective studies. Models will be used to predict: if AF led to HF, or HF led to AF in AF-HF patients where the index disease is unknown, response to rhythm control therapy in AF-HF patients and in which AF-HF patient’s rate or rhythm control is best. This proposal outlines an ambitious high risk/return program to address key technical challenges in bringing predictive patient specific models into clinical studies and will apply these innovative techniques to address important clinical questions on the treatment of patients suffering AF-HF.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores